PIZZOLO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 17.455
EU - Europa 15.060
AS - Asia 6.319
SA - Sud America 173
OC - Oceania 35
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 18
Totale 39.092
Nazione #
US - Stati Uniti d'America 17.375
GB - Regno Unito 6.028
CN - Cina 3.851
SG - Singapore 1.896
SE - Svezia 1.472
IT - Italia 1.437
FR - Francia 1.169
RU - Federazione Russa 1.135
IE - Irlanda 1.097
DE - Germania 1.019
FI - Finlandia 988
UA - Ucraina 395
BR - Brasile 145
BE - Belgio 115
TR - Turchia 104
JP - Giappone 103
KR - Corea 68
CA - Canada 67
IN - India 60
IR - Iran 57
VN - Vietnam 44
NL - Olanda 40
AU - Australia 27
ID - Indonesia 23
CH - Svizzera 20
CZ - Repubblica Ceca 20
RO - Romania 19
ES - Italia 15
LT - Lituania 14
EU - Europa 13
BG - Bulgaria 11
HK - Hong Kong 11
IQ - Iraq 11
PK - Pakistan 11
PL - Polonia 11
IL - Israele 9
AZ - Azerbaigian 8
MA - Marocco 8
NZ - Nuova Zelanda 8
AT - Austria 7
PE - Perù 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
AR - Argentina 6
BD - Bangladesh 6
EG - Egitto 6
HU - Ungheria 6
KG - Kirghizistan 6
LV - Lettonia 6
NP - Nepal 6
A2 - ???statistics.table.value.countryCode.A2??? 5
CL - Cile 5
CO - Colombia 5
MX - Messico 5
NO - Norvegia 5
PA - Panama 5
UZ - Uzbekistan 5
LA - Repubblica Popolare Democratica del Laos 4
MY - Malesia 4
PT - Portogallo 4
SA - Arabia Saudita 4
TG - Togo 4
AL - Albania 3
DK - Danimarca 3
DZ - Algeria 3
JO - Giordania 3
KZ - Kazakistan 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
BY - Bielorussia 2
EC - Ecuador 2
EE - Estonia 2
HR - Croazia 2
KH - Cambogia 2
LU - Lussemburgo 2
MD - Moldavia 2
PH - Filippine 2
TN - Tunisia 2
YE - Yemen 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
GR - Grecia 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
ME - Montenegro 1
MK - Macedonia 1
MS - Montserrat 1
NG - Nigeria 1
PS - Palestinian Territory 1
PY - Paraguay 1
SI - Slovenia 1
SM - San Marino 1
Totale 39.091
Città #
Southend 5.299
Jacksonville 3.683
Chandler 2.484
Woodbridge 2.116
Singapore 1.524
Ann Arbor 1.394
Ashburn 1.230
Houston 1.169
Dublin 1.095
Beijing 474
Wilmington 472
Lawrence 445
Princeton 445
Jinan 442
Nanjing 412
Shenyang 349
New York 273
Hebei 229
Boardman 200
Verona 194
Sindelfingen 185
Tianjin 172
Helsinki 160
Zhengzhou 146
Changsha 144
Nanchang 139
Haikou 131
Milan 126
Ningbo 121
Hangzhou 117
Brussels 110
Taizhou 109
Jiaxing 106
Philadelphia 84
Taiyuan 83
Guangzhou 81
Seattle 77
Falls Church 75
Washington 75
Norwalk 71
Lancaster 65
Seoul 59
Dearborn 57
Auburn Hills 56
Fuzhou 55
Santa Clara 53
Düsseldorf 51
Los Angeles 51
Rome 50
Redmond 49
Fairfield 47
Lanzhou 45
Toronto 37
Dallas 35
Moscow 33
Dong Ket 30
Leawood 28
San Francisco 28
Tokyo 28
Cambridge 27
Redwood City 27
São Paulo 25
Kochi 24
Bologna 23
Kent 22
Zanjan 22
Chicago 19
Tappahannock 19
Jakarta 18
Paris 17
San Mateo 17
Clearwater 15
Frankfurt am Main 15
London 14
San Diego 14
Ardabil 13
Kemerovo 13
Detroit 12
Edinburgh 12
Florence 12
Manchester 12
Padova 12
Columbus 11
Fremont 11
Genova 11
Napoli 11
Riva 11
Augusta 10
Groningen 10
Lonigo 10
Melbourne 10
Nürnberg 10
Romola 10
Amsterdam 9
Madrid 9
Ypsilanti 9
Brno 8
Genoa 8
Munich 8
Ottawa 8
Totale 27.676
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 426
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 357
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 328
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 270
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 264
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 191
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 170
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 160
Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection 160
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 158
Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts 155
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 152
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 151
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 145
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 144
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 142
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 140
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 139
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 139
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 137
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 135
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 132
Fluoride resistant alpha-naphthyl acetate esterase and combined enzyme histochemistry in the study of normal and pathologic lymphoid tissues 130
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 128
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 128
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 128
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 128
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 127
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 127
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 126
An unusual case of acute leukaemia 125
I marcatori delle cellule linfoidi 125
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 124
a (p55) and b (p75) chains of interleukin-2 receptor are expressed by AML blasts 124
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 124
Prognostic factors in acute non-lymphocytic leukemia with respect to treatment response 123
Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen 123
Expression of extracellular matrix molecules, proliferation markers and cyclin-dependent kinase inhibitors in inflamed tissues 122
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 122
Blastic OKT6-positive proliferation preceding malignant histiocytosis 122
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia 122
α-bisabolol is an effective proapoptotic agent against BCR-ABL+ cells in synergism with Imatinib and Nilotinib 122
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 122
Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues 121
Hyaline-vascular type of Castleman's disease (angiofollicular lymph node hyperplasia) with monotypic plasma cells. An immunohistochemical study with monoclonal antibodies 121
Biological prognostic factors in indolent lymphoma 121
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 121
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 121
Immunohistochemical differentiation of follicular lymphoma from florid reactive follicular hyperplasia with monoclonal antibodies reactive on paraffin sections 120
Immunologic abnormalities in angioimmunoblastic lymphadenopathy 119
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin 119
BCR-signaling profiles associated with prognosis and progression in B-CLL 118
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 117
Abnormal expansions of polyclonal large to small size granular lymphocytes: reactive or neoplastic process? 116
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 115
A study of the crosstalk between CD30 and CXCR4 115
IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells 114
Common acute lymphoblastic leukaemia-lymphoma expressing cytokeratin: a case report 114
Acute leukemia and pregnancy. Case report 114
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 114
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis 114
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 114
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 114
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 114
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 113
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 113
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies 113
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro 112
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 112
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 112
G-CSF-stimulated neutrophils are a prominent source of functional BLyS 112
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lymphoma 111
Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 granulocytopenic patients with hematological malignancies 111
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 111
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 111
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 110
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 109
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 109
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 109
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 109
BCR-signaling profiles associated with prognosis and progression in B-CLL 109
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 109
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 109
A rapid immunostaining method for frozen sections 108
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 108
Detection of calbindin-D immunoreactivity in human follicular dendritic cells 108
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 108
Underdiagnosed systemic mastocytosis: The role of flow cytometry 108
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 108
Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia 107
Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells 107
Bronchoalveolar lavage and lung histology. Comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis 106
Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease 106
Multipotent stem cell with neural differentiation potential reside in the leptomeninges 106
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 106
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 106
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course. 106
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 105
Immunohistochemical evidence of active thymocyte proliferation in thymoma. Its possible role in the pathogenesis of autoimmune diseases 105
Routine immunofluorescent and histochemical analysis of bone marrow involvement of lymphoma/leukaemia: the use of cryostat sections 105
Totale 13.190
Categoria #
all - tutte 120.756
article - articoli 86.854
book - libri 0
conference - conferenze 32.369
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.533
Totale 241.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.190 0 0 0 0 0 692 398 498 218 512 173 699
2020/20214.722 315 734 231 500 537 613 58 419 372 40 700 203
2021/20223.812 331 1.091 44 264 212 118 76 203 135 142 389 807
2022/20237.250 582 583 658 1.295 744 1.768 59 473 771 42 181 94
2023/20243.451 174 297 300 391 356 501 188 431 18 124 409 262
2024/20253.508 600 595 220 1.458 472 163 0 0 0 0 0 0
Totale 39.402